Study of E7777 in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma and Cutaneous T-cell Lymphoma

NCT02676778 PHASE2 COMPLETED Results posted

The purpose of this study is to evaluate the objective response rate (ORR) of E7777 in participants with relapsed or refractory peripheral T-cell lymphoma (PTCL) and cutaneous T-cell lymphoma (CTCL).

Details

Lead sponsor	Eisai Co., Ltd.
Phase	PHASE2
Status	COMPLETED
Enrolment	45
Start date	Mon Mar 28 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Fri Apr 26 2019 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Peripheral T-cell Lymphoma
• Cutaneous T-cell Lymphoma

Interventions

• E7777

Countries

Japan